LOC14

CAS No. 877963-94-5

LOC14 ( —— )

Catalog No. M20192 CAS No. 877963-94-5

LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 73 In Stock
25MG 154 In Stock
50MG 279 In Stock
100MG 489 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LOC14
  • Note
    Research use only not for human use.
  • Brief Description
    LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).
  • Description
    LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PDI
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    877963-94-5
  • Formula Weight
    317.4
  • Molecular Formula
    C16H19N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:25 mg/mL?(78.76 mM)
  • SMILES
    O=C(C1CC1)N1CCN(Cn2sc3ccccc3c2=O)CC1
  • Chemical Name
    2-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]methyl]-12-benzisothiazol-3(2H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kaplan A et al. Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective. Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2245-52.
molnova catalog
related products
  • IRBP (1-20), human

    IRBP (1-20), human is the 1-20 fragment of interphotoreceptor retinoid binding protein (IRBP).This peptide is a 1 to 20 amino acid fragment of the interphotoreceptor retinoid binding protein (IRBP). IRBP is a 140-kDa glycolipoprotein residing in the interphotoreceptor matrix between the neural retina and the retinal pigment epithelium.

  • Methyl octanoate

    Methyl octanoate is a volatile compound and an aroma component persimmon wine.

  • Oxiniacic Acid

    Nicotinic acid N-oxide is used to treat hyperlipoidemia.